Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumors × Tablets × Clear all

Sponsor

Conditions

Neoplasms 4 Leukemia, B-Cell 2 Urinary Bladder Neoplasms 1 Polycystic Ovary Syndrome 1 Parathyroid Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia 1 Hyperparathyroidism, Primary 1 Head and Neck Neoplasms 1 Diabetes Mellitus 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Gemcitabine 4 Nivolumab 3 cobimetinib 2 atezolizumab 2 Ramucirumab 2 Paclitaxel 2 zansecimab 1 tocilizumab 1 tivozanib 1 tislelizumab 1 temsirolimus 1 ridaforolimus 1 plocabulin 1 pembrolizumab 1 pamiparib 1 obinutuzumab 1 necitumumab 1 liposomal doxorubicin 1 lenvatinib 1 glasdegib 1 futuximab 1 demplatin pegraglumer 1 birinapant 1 adavosertib 1 Temozolomide 1 TAK-981 1 Sunitinib 1 Specimen Handling 1 Panitumumab 1 PM 01183 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡